Drug Discovery Outsourcing Market Forecast 2016-2026

創薬アウトソーシングの世界市場予測2016-2026

◆タイトル:Drug Discovery Outsourcing Market Forecast 2016-2026
◆商品コード:VGAIN61119
◆調査・発行会社:visiongain
◆発行日:2016年9月
◆ページ数:232
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Sigle User(1名利用)GBP1,999 ⇒換算¥299,850見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥449,850見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥749,850見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、創薬アウトソーシングの世界市場について調査・分析し、創薬アウトソーシングの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。
1. レポート概要

2. 創薬アウトソーシングの概要

3. 創薬アウトソーシングの世界市場およびサービス分野2次市場2016-2026

4. 創薬アウトソーシング市場における主要国市場2015-2026

5. 創薬アウトソーシング市場における主要企業

6. 創薬アウトソーシング市場の定性分析2016-2026

7. 専門家の意見

8. 結論

Where is the drug discovery outsourcing market heading? Visiongain’s new report gives you revenue predictions for the drug discovery outsourcing market and its submarkets from 2016 to 2026, helping you stay ahead.

Visiongain’s new 232-page report provides revenue forecasts to 2026 for the global drug discovery outsourcing market, four leading submarkets and 13 leading national markets. The report profiles 14 leading CROs providing drug discovery outsourcing, and includes revenue forecasts and analysis to 2026 for 6 of those companies. It also includes 3 interview transcripts with industry experts regarding the current developments and the drivers of growth in the drug discovery outsourcing market.

Besides revenue forecast to 2026, this report provides market shares, business outlooks, qualitative analyses (including SWOT and Porter’s Five Forces Analysis), company profiles and commercial partnerships.

See revenue forecasts for leading drug discovery outsourcing sectors
Along with prediction of overall world market value to 2026, our report shows you revenue forecasting for the four services sectors at world level:
• Chemistry services market forecast 2016-2026
• Biology services market forecast 2016-2026
• Lead optimisation market forecast 2016-2026
• Lead identification and screening market forecast 2016-2026

The analysis helps you identify market potential with individual revenue forecasts, annual growth rates and CAGRs and market shares.

Discover prospects of the leading national markets for the drug discovery outsourcing
The drug discovery outsourcing market is becoming increasingly global as companies look to lower costs by off-shoring their work to CROs based in emerging economies.

You will discover individual revenue forecasts, annual growth rates, CAGRs, and market shares to 2026, as well as written supporting analyses for each of the 13 leading national markets and the rest of the world (RoW):
• US
• Japan
• Germany
• France
• UK
• Italy
• Spain
• China
• Brazil
• Russia
• India
• South Korea
• Mexico
• Rest of the World

Demand for CROs based in emerging markets will be a major driver of growth in this market.

Leading companies and potential for market growth
Our new study predicts the world market for drug discovery outsourcing will reach $19.2bn in 2016. There is the increasing trend for pharmaceutical and biotech companies to form partnerships and alliances with CROs during the early drug discovery phase.

Our research profiles leading companies, assessing their financial performance and products. You will see which organisations hold the greatest potential and what services each offer. See the profiles of 14 leading companies:
• Albany Molecular Research (AMRI)
• Aptuit
• Charles River Laboratories
• Covance
• Cyprotex
• Domainex
• Evotec
• GenScript
• Pharmaceutical Product Development (PPD)
• Quintiles
• Selcia
• Viva Biotech
• WIL Research Laboratories
• WuXi AppTec

【レポートの目次】

1. Report Overview
1.1 The Drug Discovery Outsourcing Market Overview
1.2 Drug Discovery Outsourcing Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports

2. An Introduction to Drug Discovery Outsourcing
2.1 What is Outsourcing?
2.2 What is Drug Discovery Outsourcing?
2.3 Why Outsource Drug Discovery?
2.4 A Common Drug Discovery Model Includes Pharmaceutical Organizations Collaborating with Academia
2.5 The Outsource Model for Drug Development Increases Innovation
2.6 Outsourced Processes in Drug Discovery
2.7 Challenges with Drug Discovery Outsourcing
2.8 Emerging Markets are a Popular Destination for CROs
2.9 Strategic Partnerships to Acquisitions
2.10 Recent Drug Development Outsourcing Agreements
2.11 Glossary of Terms Related to Drug Discovery Outsourcing

3. Global Drug Discovery Outsourcing Market and Service Area Submarkets, 2016-2026
3.1 Drug Discovery Outsourcing: Global Market Overview
3.2 The Global Drug Discovery Outsourcing Market Sectors
3.3 The Global Drug Discovery Outsourcing Market by Sector, 2015
3.4 The Global Drug Discovery Outsourcing Market by Sector, 2015-2026
3.5 The Changing Market Shares by Sector, 2015-2026
3.6 The Global Chemistry Services Outsourcing Market, 2015
3.6.1 Libraries
3.6.2 Building Blocks
3.6.3 Compound Synthesis
3.6.4 The Global Chemistry Services Outsourcing Market Forecast, 2015-2026
3.7 The Global Biology Services Outsourcing Market, 2015
3.7.1 Target Identification
3.7.2 Target Validation
3.7.3 The Global Biology Services Outsourcing Market Forecast, 2015-2026
3.8 The Global Lead Optimisation Market, 2015
3.8.1 ADMET Screening: Prevents Late Stage Failure of Clinical Trials
3.8.2 The Global Lead Optimisation Market Forecast, 2015-2026
3.9 The Global Lead Identification and Screening Outsourcing Market, 2015
3.9.1 Methods of Screening in Drug Discovery
3.9.2 Primary Screening
3.9.3 The Global Lead Identification and Screening Outsourcing Market Forecast, 2015-2026

4. The Leading National Markets in the Drug Discovery Outsourcing Market 2015-2026
4.1 Drug Discovery Outsourcing Overview
4.2 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015
4.3 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
4.4 The Changing Market Shares of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
4.5 CAGRs of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026
4.6 The US Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7 The EU5 Drug Discovery Outsourcing Market by Region, 2015
4.7.1 The EU5 Drug Discovery Outsourcing Market Forecast, 2015-2026
4.7.2 CAGRs by EU5 Region, 2015-2026
4.7.3 The EU5 Changing Market Shares by Country 2015-2026
4.7.3.1 The German Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.2 The UK Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.3 The French Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.4 The Italian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.7.3.5 The Spanish Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.8 The Japanese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.9 The Chinese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.9.1 Challenges to China’s Growth
4.10 The Indian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.11 The Brazilian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.12 The Russian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.13 The South Korean Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.14 The Mexican Drug Discovery Outsourcing Market Sales Forecast, 2015-2026
4.15 The Rest of the World Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

5. Leading Companies in the Drug Discovery Outsourcing Market
5.1 Drug Discovery Outsourcing: A Fragmented and Growing Marketplace
5.2 Characteristics of Leading Contract Research Organisations
5.2.1 A Highly Quality Workforce
5.2.2 Emphasis on Intellectual Property Protection
5.2.3 Long Term Working Relationship
5.2.4 Success in Project Completion
5.2.5 Internal Drug Discovery Programmes
5.3 Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market
5.4 Albany Molecular Research (AMRI)
5.4.1 Historical Sales and Recent Financial Performance, 2011-2014
5.4.2 AMRI’s Drug Discovery Services
5.4.3 Internal Portfolio of Drug Discovery and Development Programme Collaborations
5.4.4 AMRI (DDS) Sales Forecast, 2015-2026
5.5 Aptuit
5.5.1 INDIGO: Accelerating Early Drug Candidates
5.5.2 Aptuit Clinical Trial Supplies
5.5.3 Strategic Partnerships, Acquisitions and Divestitures
5.5.3.1 Divestiture of Aseptic Clinical Manufacturing
5.5.3.2 Aptuit’s Extended Partnership with GSK for VeronaCentre
5.5.3.3 Partnership with Siena Biotech
5.5.3.4 Partnership with Laurus Labs
5.6 Charles River Laboratories
5.6.1 Sales and Historical Financial Performance, 2011-2014
5.6.2 Charles River Laboratories: An External Acquisition Strategy
5.6.2.1 Acquisition of ChanTest
5.6.2.2 Acquisition of Galapagos’ CRO Services Division (BioFocus and Argenta)
5.6.2.3 Acquisition of VivoPath
5.6.3 Charles River Laboratories: Revenue and Financial Analysis, 2014
5.6.3.1 Charles River Laboratories: Historical Financial Performance by Business Segment, 2013-2014
5.6.4 Charles River Laboratories Sales Forecast, 2015-2026
5.7 Covance (Acquired by Laboratory Corporation of America)
5.7.1 Covance: Historical Revenue and Financial Performance, 2010-2013
5.7.2 Covance: Early Stage Discovery Efforts
5.7.3 Agreement with Sanofi
5.7.4 Agreement with Kellogg Company
5.7.5 Agreement with Bio Pontis Alliance
5.7.6 Agreement with Indiana Clinical and Translational Sciences Institute (CTSI)
5.7.7 Agreement with EliLilly
5.8 Cyprotex
5.8.1 Historical Revenue and Financial Performance, 2011-2014
5.8.2 Cyprotex: Revenue by Region, 2015
5.8.3 Cyprotex: Revenue Analysis and Forecast 2015-2026
5.9 Domainex
5.9.1 Drug Pipeline
5.9.2 TBK1/ IKKεInhibitors
5.9.3 Methyltransferase (KMTS) Inhibitors
5.10 Evotec
5.10.1 Strategic Action Plan
5.10.2 Evotec: Historical Revenue and Financial Analysis, 2010-2014
5.10.3 EVT Integrate and EVT Innovate
5.10.4 Partnerships with Pharma for Drug Discovery
5.10.4.1 Partnership with Sanofi
5.10.4.2 Extended Partnership with Evotec
5.10.4.3 Partnership with Johnson & Johnson
5.10.4.4 Partnership with AstraZeneca
5.10.4.5 Partnership with Bayer Pharmaceuticals
5.10.4.6 Partnership with Boehringer Ingelheim Pharma
5.10.4.7 Collaboration with CHDI
5.10.4.8 Collaboration with Janssen
5.10.4.9 Collaboration with MedImmune
5.10.4.10 Collaboration with UCBPharma
5.10.5 Evotec Sales Forecast, 2015-2026
5.11 GenScript
5.11.1 GenScript: Agreements and Partnerships
5.12 Pharmaceutical Product Development (PPD)
5.12.1 PPD: Agreements, Strategic Partnerships and Private Merger
5.12.1.1 Acquisition of Acurian
5.12.1.2 Partnership with Elan
5.12.1.3 Partnership with GSK
5.13 Quintiles
5.13.1 Quintiles: Historical Revenue and Financial Performance, 2009-2014
5.13.2 Development Deal With Merck
5.13.3 Quintiles: Acquisition of Advion Bioanalytical Labs
5.13.4 Quintiles: SheddingJobs
5.13.5 Quintiles Sales Forecast, 2015-2026
5.14 Selcia
5.14.1 A Strong Natural Product Chemistry Track Record
5.14.2 Initiative with the University of Edinburgh
5.14.3 Collaboration with Cantab
5.15 Viva Biotech
5.15.1 GPCR Targeted Discovery Programs
5.15.2 Antibody Therapeutics Discovery
5.16 WIL Research Laboratories
5.16.1 Focus on Preclinical Research
5.16.2 Acquisition of Ricerca Biosciences LLC
5.16.3 Acquisition of Midwest Bio Research
5.17 WuXi Apptec
5.17.1 WuXi AppTec: Service Offerings
5.17.2 Acquisition of Next CODE Health
5.17.3 WuXiAppTec: Historical Revenue and Financial Performance, 2010-2014
5.17.4 WuXiAppTec: Laboratory Services Sales Forecast, 2015-2026

6. Quantitative Analysis of the Drug Discovery Outsourcing Market, 2016-2026
6.1 Drivers and Restraints in the Drug Discovery Outsourcing Market, 2016-2026
6.2 SWOT Analysis of the Drug Discovery Outsourcing Market, 2016-2026
6.3 Strengths
6.3.1 Cost Reduction: A Central Driver for Outsourcing
6.3.2 Accelerating the Discovery of Drug Candidates
6.3.3 Growth of Virtual Pharmaceutical Companies
6.3.4 Reduction in R&D capacity Within Big Pharma
6.4 Weaknesses
6.4.1 Slowing Trajectory of Growth for R&D Spending
6.4.2 Increasingly Saturated Market Requires Companies to Quickly Evolve
6.5 Opportunities
6.5.1 The Available Scope for the Expansion of CROs
6.5.2 Targeted Therapies: Advances in Biologics and Orphan Drugs
6.5.3 Increasing Development of Biologics and Biosimilars
6.6 Threats
6.6.1 A Competitive Market is Increasing Consolidation
6.6.2 Threat of Private Public Alliances
6.6.3 Intellectual Property Leaks
6.6.4 Challenges of Technology Transfer
6.7 Porter’s Five Force Analysis of the Drug Discovery Outsourcing Market
6.7.1 Threat of New Entrants: Medium
6.7.2 Power of Suppliers: Medium
6.7.3 Threat of Substitutes: Medium
6.7.4 Power of Buyers: High
6.7.5 Rivalry Among Competitors: High

7. Expert Opinions
7.1 Interview with Dr. Mario Polywka, Chief Operating Officer, Evotec
7.1.1 Bridging the Gap Between Academia and BigPharma
7.1.2 Evotec: Specialises in Certain Disease Therapies
7.1.3 Complete Drug Discovery Outsourcing: A Growing Trend
7.1.4 Strategies for Drug Discovery Outsourcing Expansion
7.1.5 Building Trust in Collaborations
7.1.6 Evotec: Proven Track Record of Success
7.2 Dr. John Davis, Director of Discovery and Dave Roberts, Business Development Director, Radiochemistry, Selcia
7.2.1 Growth in the Full Spectrum of Outsourcing Services
7.2.2 Natural Products: Increasing Source of Drug Discovery
7.2.3 Strong Pool of Early Drug Candidates
7.2.4 Overcoming Drug Discovery Challenges using Drug Discovery
7.2.5 Selcia: Regional Base of Clients
7.2.6 Drug Discovery and Emerging Technologies
7.2.7 Med Chem Plus Projects
7.2.8 Varied Customer Base
7.2.9 CROs: Improving Drug Discovery Productivity Levels?
7.3 Interview with Dr. Paul Overton, Executive VP, Business Development & Marketing, Aptuit
7.3.1 End-to-End Drug Discovery Integration Growth
7.3.2 Whole Project Externalisation
7.3.3 Drug Discovery Outsourcing: One of Aptuit’s Fastest Growing Services
7.3.4 Aptuit INDiGO® Program
7.3.5 Aptuit Implementation Drug Discovery Acquisitions
7.3.6 Aptuit: Adding the Intellectual Capabilities for Drug Discovery
7.3.7 Several Partners in the Drug Discovery Model

8. Conclusion
8.1 Market Overview
8.2 Lead Optimisation will be the Fastest Growing Sector
8.3 The Drug Discovery Outsourcing Market in Emerging Market Shows Huge Gains
8.4 Continued Growth in Alliances and Collaborations
8.5 Concluding Remarks

List of Tables
Table 1.1 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 1.2 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 2.1 Indication of Functions Outsourced in the Different Stages of the Drug R&D Process, 2016
Table 2.2 Selected Drug Discovery Outsourcing Alliances, 2013-2016
Table 2.2 (Cont’d) Selected Drug Discovery Outsourcing Alliances, 2013-2016
Table 3.1 PhMRA’s Historical Estimate for its Member’s Total R&D Spending ($bn), 1980-2015
Table 3.2 The Global Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Sector, 2015
Table 3.3 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026
Table 3.4 The Global Drug Discovery Outsourcing Market: Revenue Share (%) by Sector, 2015 , 2020 and 2026
Table 3.5 The Chemistry Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026
Table 3.6 The Biology Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026
Table 3.7 The Lead Optimisation Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026
Table 3.8 Selected Source for Lead Compounds, 2015
Table 3.9 The Lead Identification and Screening Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.1 The Global Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Region, 2015
Table 4.2 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Region, 2015-2026
Table 4.2.1 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Region, 2015-2026
Table 4.3 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2015, 2020, 2026
Table 4.4 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2015-2020, 2020-2026, 2015-2026
Table 4.5 The US Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.6 The US Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.7 The EU5 Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Region, 2015
Table 4.8 The EU5 Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.9 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2015-2020, 2020-2026, and 2015-2026
Table 4.10 The EU5 Drug Discovery Outsourcing Market: Market Shares (%) by Country, 2015, 2020, 2026
Table 4.11 The German Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.12 The German Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.13 The UK Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.14 The UK Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.15 The French Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.16 The French Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.17 The Italian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.18 The Italian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.19 The Spanish Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.20 The Spanish Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.21 The Japanese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.22 The Japanese Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.23 The Chinese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.24 The Chinese Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.25 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.26 The Indian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.27 The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.28 The Brazilian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.29 The Russian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.30 The Russian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.31 The South Korean Drug Discovery Outsourcing MarketForecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.32 The South Korean Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.33 The Mexican Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 4.34 The Mexican Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026
Table 4.35 The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 5.1 Albany Molecular Research (AMRI): Historical Revenue ($m), 2011-2014
Table 5.2 AMRI: Service Offerings and Descriptions, 2015
Table 5.3 AMRI: Drug Discovery and Development Programmes and Project Stage, 2015
Table 5.4 AMRI (DDS) Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
Table 5.5 Aptuit: Services Offered and their Descriptions, 2015
Table 5.6 Charles River Laboratories: Services Offered by Segment, 2016
Table 5.7 Charles River Laboratories: Revenue ($m), AGR (%), 2011-2014
Table 5.8 Charles River Laboratories: Revenue ($m) by Segment, 2011-2014
Table 5.9 Charles River Laboratories: Revenue ($bn) by Business Segment, 2013-2014
Table 5.10 Charles River Laboratories Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
Table 5.11 Covance: Historical Revenue ($bn) by Business Segment, 2010-2013
Table 5.12 Selected Cyprotex Partnerships, 2015
Table 5.13 Cyprotex: Historical Revenue ($m), (£m), AGR (%), 2011-2014
Table 5.14 Cyprotex: Revenue ($m), Revenue Share (%) by Region, 2015
Table 5.15 Cyprotex Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
Table 5.16 Cyprotex Selected Collaborations
Table 5.17 Evotec: Historical Revenue ($m), 2010-2014
Table 5.18 Evotec: Discovery Pipeline, 2016
Table 5.19 Evotec Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
Table 5.20 GenScript: Services Offered and Descriptions, 2015
Table 5.21 Quintiles: Revenue ($bn), AGR (%), 2009-2014
Table 5.22 Quintiles Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 5.23 Selcia: Drug Discovery Services Portfolio, 2015
Table 5.24 VivaBiotech: Service Offerings, 2015
Table 5.25 WuXiAppTec: Pharmaceutical Laboratory Services and Descriptions, 2016
Table 5.26 WuXiAppTec: Historical Revenue ($m), AGR (%) by Business Segment, 2010-2014
Table 5.27 WuXiAppTec Laboratory Services Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
Table 6.1 SWOT Analysis of the Drug Discovery Outsourcing Industry, 2016-2026
Table 8.1 The Global Drug Discovery Outsourcing Market Forecast:
Revenue ($bn), CAGR (%), 2015, 2020, 2026
Table 8.2 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Sector, 2015, 2020, 2026
Table 8.3 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Emerging Market, 2015, 2020 and 2026

List of Figures
Figure 1.1 The Drug Discovery Outsourcing Market: Overview of Submarkets
Figure 2.1Selected Tasks being Outsourced in the Pharma Industry, 2016
Figure 2.2 Stages of the Drug Development Cycle
Figure 3.1 PhMRA’s Historical Estimate for its Member’s Total R&D Spending ($bn), 1980-2015
Figure 3.2 Attrition Rate of Compounds at the Developmental Stages
Figure 3.3 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Sector, 2015
Figure 3.4 The Global Drug Discovery Outsourcing Market: Market Share (%) by Sector, 2015
Figure 3.5 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 3.6 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Sector, 2020
Figure 3.7 The Global Drug Discovery Outsourcing Market: Market Shares (%)by Sector, 2026
Figure 3.8 The Chemistry Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 3.9 The Biology Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 3.10 An Overview of ADMET Screening in Drug Discovery
Figure 3.11 The Lead Optimisation Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 3.12 Typical Steps in the Lead Screening Process
Figure 3.13 The Lead Identification and Screening Outsourcing Market a Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.1 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Region, 2015
Figure 4.2 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2015
Figure 4.3 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2020
Figure 4.4 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2026
Figure 4.5 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2015-2020
Figure 4.6 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2020-2026
Figure 4.7 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2015-2026
Figure 4.8 The US Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.9 The EU5 Drug Discovery Outsourcing Market: Market Revenue ($bn) by EU5 Country, 2015
Figure 4.10 The EU5 Drug Discovery Outsourcing Market: Market Share (%) by Region, 2015
Figure 4.11 The EU5 Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.12 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2015-2020
Figure 4.13 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2020-2026
Figure 4.14 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2015-2026
Figure 4.15 The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares (%) by Country, 2020
Figure 4.16 The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares (%) by Country, 2026
Figure 4.17 The German Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.18 The UK Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.19 The French Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.20 The Italian Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), 2015-2026
Figure 4.21 The Spanish Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.22 The Japanese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.23 The Chinese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.24 The Chinese Population Demographics: Over 65 population and Forecast (millions) , 1950, 2010, 2050
Figure 4.25 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.26 The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.27 The Russian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.28 The South Korean Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.29 The Mexican Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 4.30 The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 5.1 Albany Molecular Research (AMRI): Historical Revenue ($m), 2011-2014
Figure 5.2 AMRI (DDS) Forecast: Revenue ($m), AGR (%), 2015-2026
Figure 5.3 Charles River Laboratories: Revenue ($m), AGR (%), 2011-2014
Figure 5.4 Charles River Laboratories: Revenue Share (%) by Segment, 2014
Figure 5.5 Charles River Laboratories: Revenue ($bn), 2013-2014
Figure 5.6 Charles River Laboratories: Revenue Share (%) by Business Segment, 2014
Figure 5.7 Charles River Laboratories Forecast: Revenue ($m), AGR (%), 2015-2026
Figure 5.8 Covance: Historical Revenue ($bn), 2010-2013
Figure 5.9 Covance: Revenue Share (%) by Segment, 2013
Figure 5.10 Cyprotex: Historical Revenue ($m), AGR (%), 2011-2014
Figure 5.11 Cyprotex: Revenue Share(%) by Region, 2015
Figure 5.12 Cyprotex Forecast: Revenue ($m), AGR (%), 2015-2026
Figure 5.13 Domainex: Drug Pipeline by Indication, 2015
Figure 5.14 Evotec: Historical Revenue ($m) 2010-2014
Figure 5.15 Evotec Forecast: Revenue ($m), AGR (%), 2015-2026
Figure 5.16 Quintiles: Historical Revenue ($bn), AGR (%), 2009-2014
Figure 5.17 Quintiles Forecast: Revenue ($bn), AGR (%), 2015-2026
Figure 5.18 WuXiAppTec: Historical Revenue ($m) for Laboratory Services, 2010-2014
Figure 5.19 WuXiAppTec Laboratory Services Forecast: Revenue ($m), AGR (%), 2015-2026
Figure 6.1 The Drug Discovery Outsourcing Market: Drivers and Restraints, 2016-2026
Figure 6.2 Porter’s Five Analysis of the Companion Diagnostics Market, 2016-2026
Figure 8.1 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), 2015, 2020, 2026
Figure 8.2 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Sector, 2015, 2020, 2026
Figure 8.3 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Emerging Market, 2015, 2020 and 2026

★調査レポート[創薬アウトソーシングの世界市場予測2016-2026] ( Drug Discovery Outsourcing Market Forecast 2016-2026 / VGAIN61119) 販売に関する免責事項
[創薬アウトソーシングの世界市場予測2016-2026] ( Drug Discovery Outsourcing Market Forecast 2016-2026 / VGAIN61119) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆